US 10471144
Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
granted A61KA61K2039/505A61K31/352
Quick answer
US patent 10471144 (Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer) held by Provectus Pharmatech, Inc. expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K31/352, A61K31/365, A61K38/193